Some patients addicted to opioids may be spiking their drug tests to mimic adherence to their treatment plans, undermining attempts to address an epidemic that looms larger than ever.

A Biogen Inc. drug that targets a rare form of ALS got partial support from a panel of US Food and Drug Administration advisers Wednesday, paving the way for a possible accelerated approval.

A Pennsylvania county has joined a handful of US school districts in filing a lawsuit against social media companies, alleging their platforms have fueled a youth mental health crisis with addictive technology and harmful targeted content.

Several claims by a former Newark, N.J., municipal court judge’s alleging disability bias and other abuses fueled her discharge were wrongly dismissed because she didn’t get a chance to collect potentially helpful evidence, a state appeal court ruled Wednesday.

A Missouri neurosurgeon and his fiancee, along with their companies, Midwest Neurosurgeons LLC and DS Medical LLC, will pay $825,000 to resolve a lawsuit alleging violations of the False Claims Act, the Justice Department said Wednesday.

From athlete’s foot to dandruff, people have long been bothered by fungal infections. But health officials are warning that more severe fungal diseases are emerging globally. Case in point: Candida auris (C. auris), a deadly, often drug-resistant yeast. First described in Japan in 2009, today it’s found around the world, including the US, where it spread rapidly during the Covid-19 pandemic. While cases remain relatively few — and healthy people generally aren’t at risk — experts say that, if left unchecked, C. auris poses a serious global threat, though far from the fungal apocalypse portrayed in the hit HBO series The Last of Us.